205 related articles for article (PubMed ID: 27592355)
1. High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
Toteda G; Lupinacci S; Vizza D; Bonofiglio R; Perri E; Bonofiglio M; Lofaro D; La Russa A; Leone F; Gigliotti P; Cifarelli RA; Perri A
J Endocrinol Invest; 2017 Feb; 40(2):153-162. PubMed ID: 27592355
[TBL] [Abstract][Full Text] [Related]
2. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
Lin SF; Lin JD; Hsueh C; Chou TC; Wong RJ
PLoS One; 2017; 12(2):e0172315. PubMed ID: 28207834
[TBL] [Abstract][Full Text] [Related]
3. Expression of human beta-defensins-1-4 in thyroid cancer cells and new insight on biologic activity of hBD-2 in vitro.
Zhuravel OV; Gerashchenko OL; Khetsuriani MR; Soldatkina MA; Pogrebnoy PV
Exp Oncol; 2014 Sep; 36(3):174-8. PubMed ID: 25265350
[TBL] [Abstract][Full Text] [Related]
4. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
6. Role of the endothelin axis in the proliferation of human thyroid cancer cells.
Donckier JE; Mertens-Strijthagen J; Flamion B
Clin Endocrinol (Oxf); 2007 Oct; 67(4):552-6. PubMed ID: 17561979
[TBL] [Abstract][Full Text] [Related]
7. Differential roles of leptin in regulating cell migration in thyroid cancer cells.
Cheng SP; Yin PH; Chang YC; Lee CH; Huang SY; Chi CW
Oncol Rep; 2010 Jun; 23(6):1721-7. PubMed ID: 20428831
[TBL] [Abstract][Full Text] [Related]
8. Targeting the proteasome as a promising therapeutic strategy in thyroid cancer.
Wunderlich A; Arndt T; Fischer M; Roth S; Ramaswamy A; Greene BH; Brendel C; Hinterseher U; Bartsch DK; Hoffmann S
J Surg Oncol; 2012 Mar; 105(4):357-64. PubMed ID: 22006286
[TBL] [Abstract][Full Text] [Related]
9. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of arsenic trioxide in transformed human thyroid cells.
Fröhlich E; Czarnocka B; Brossart P; Wahl R
Thyroid; 2008 Nov; 18(11):1183-93. PubMed ID: 19014326
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis.
Fabiani R; De Bartolomeo A; Rosignoli P; Servili M; Montedoro GF; Morozzi G
Eur J Cancer Prev; 2002 Aug; 11(4):351-8. PubMed ID: 12195161
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.
Camacho CP; Latini FR; Oler G; Hojaij FC; Maciel RM; Riggins GJ; Cerutti JM
Clin Endocrinol (Oxf); 2009 Mar; 70(3):475-83. PubMed ID: 18727708
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells.
Landriscina M; Maddalena F; Fabiano A; Piscazzi A; La Macchia O; Cignarelli M
Anticancer Res; 2010 Feb; 30(2):473-80. PubMed ID: 20332457
[TBL] [Abstract][Full Text] [Related]
15. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
17. The Hydroxytyrosol Induces the Death for Apoptosis of Human Melanoma Cells.
Costantini F; Di Sano C; Barbieri G
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137997
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
Temmim L; Ebraheem AK; Baker H; Sinowatz F
Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
[TBL] [Abstract][Full Text] [Related]
19. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
20. Hydroxytyrosol promotes superoxide production and defects in autophagy leading to anti-proliferation and apoptosis on human prostate cancer cells.
Luo C; Li Y; Wang H; Cui Y; Feng Z; Li H; Li Y; Wang Y; Wurtz K; Weber P; Long J; Liu J
Curr Cancer Drug Targets; 2013 Jul; 13(6):625-39. PubMed ID: 23597197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]